MOF-Based Arginine Nanocarriers for Coordinated Immunometabolic and Antitumor Modulation in Triple Negative Breast Cancer

Biomater. Sci., 2026, Accepted Manuscript
DOI: 10.1039/D6BM00195E, Paper

Open Access

&nbsp This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Amir M Alsharabasy, Aibhe Boran, Roberto González-Gómez, Harry Campton, Abhay Pandit, Pau Farràs
L-arginine (L-Arg) is a key immunometabolite and nitric oxide (●NO) precursor with therapeutic potential in cancer and immunotherapy. However, its clinical application is hindered by poor bioavailability and uncontrolled dosing....
The content of this RSS Feed (c) The Royal Society of Chemistry